XML 22 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
May. 01, 2016
May. 03, 2015
Cash flows from operating activities:    
Net income (loss) $ 8,312 $ (7,808)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 21,512 23,497
Deferred financing cost amortization 954 118
Share-based compensation expense 5,050 5,134
Gain from bargain purchase (1,864) 0
Gain on sale of assets and asset recovery (1,652) (26)
(Recovery of) provision for doubtful accounts 1,898 (129)
Provision for deferred income taxes 1,668 5,506
Excess tax (benefits) shortfalls from share-based compensation arrangements 390 (384)
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 25,299 30,268
Inventories 6,555 1,660
Income taxes receivable (4,140) (6,373)
Prepaid expenses and other 3,699 (176)
Accounts payable (24,633) (25,044)
Accrued expenses (22,976) (28,910)
Other, net (59) (634)
Net cash provided by (used in) operating activities 20,013 (3,301)
Cash flows from investing activities:    
Acquisitions, net of cash acquired (4,343) (247,123)
Capital expenditures (10,280) (9,307)
Proceeds from sale of property, plant and equipment 4,663 26
Net cash used in investing activities (9,960) (256,404)
Cash flows from financing activities:    
Deposit of restricted cash (49) 0
Proceeds from stock options exercised 1,401 354
Issuance of debt 0 250,000
Payments on term loan (20,000) (21,239)
Payments on note payable (531) (417)
Payment of financing costs 0 (8,879)
Excess tax benefits (shortfalls) from share-based compensation arrangements (390) 384
Purchases of treasury stock (12,381) (1,539)
Net cash provided by (used in) financing activities (31,950) 218,664
Effect of exchange rate changes on cash and cash equivalents 151 (334)
Net decrease in cash and cash equivalents (21,746) (41,375)
Cash and cash equivalents at beginning of period 99,662 66,651
Cash and cash equivalents at end of period $ 77,916 $ 25,276